BUZZ-Rapid Micro Biosystems rises as Samsung Biologics orders more automation systems

Rapid Micro Biosystems, Inc. Class A +5.09%

Rapid Micro Biosystems, Inc. Class A

RPID

2.27

+5.09%

** Shares of drug manufacturing firm Rapid Micro Biosystems RPID.O rise 3% to $4.50 premarket

** Co says it won a new multi-system order from Samsung Biologics to deploy its Growth Direct platform

** Growth Direct automates microbial quality checks, helping drugmakers speed up safety testing for biologics and vaccines - RPID

** Order expands an existing partnership with Samsung Biologics, a major contract manufacturer for the pharma industry, co says

** CEO Robert Spignesi says the systems deliver faster results and higher accuracy as Samsung scales up manufacturing

** Shares up about three-fold in 2025


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.